Traité de gastro-entérologie. 2ème édition. Paris: Flammarion, 2005. ,
Productivité individuelle et maladie de Crohn : impact de la maladie et apport des traitements, Hépato Gastro, vol.20, pp.20-24, 2013. ,
Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from, Clin. Gastroenterol. Hepatol. Off. Clin. Pr. J. Am. Gastroenterol. Assoc, vol.11, pp.43-48, 1982. ,
Overall and cause-specific mortality in Crohn??s disease: A meta-analysis of population-based studies, Inflammatory Bowel Diseases, vol.309, issue.2, pp.347-353, 2010. ,
DOI : 10.1126/science.1114233
Overall and Cause-Specific Mortality in Ulcerative Colitis: Meta-analysis of Population-Based Inception Cohort Studies, The American Journal of Gastroenterology, vol.33, issue.3, pp.609-617, 2007. ,
DOI : 10.1016/0016-5085(91)90202-V
Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis, Inflammatory Bowel Diseases, vol.55, 2013. ,
DOI : 10.1007/s10620-009-0749-9
The Natural History of Adult Crohn's Disease in Population-Based Cohorts, The American Journal of Gastroenterology, vol.132, issue.2, pp.289-297, 2010. ,
DOI : 10.1053/j.gastro.2008.09.053
Cost Analysis and Cost Determinants in a European Inflammatory Bowel Disease Inception Cohort With 10 Years of Follow-up Evaluation, Gastroenterology, vol.131, issue.3, pp.719-728, 2006. ,
DOI : 10.1053/j.gastro.2006.05.052
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nature Genetics, vol.38, issue.3, pp.246-252, 2011. ,
DOI : 10.1046/j.1365-2036.2001.00981.x
Effects of cigarette smoking on the long-term course of Crohn's disease, Gastroenterology, vol.110, issue.2, pp.424-431, 1996. ,
DOI : 10.1053/gast.1996.v110.pm8566589
A meta-analysis of the role of smoking in inflammatory bowel disease, Digestive Diseases and Sciences, vol.284, issue.12 ,
DOI : 10.1007/BF01536701
Smoking and Inflammatory Bowel Disease: A Meta-analysis, Mayo Clinic Proceedings, vol.81, issue.11 ,
DOI : 10.4065/81.11.1462
Inflammatory Bowel Disease and Smoking, Inflammatory Bowel Diseases, vol.96, issue.6, pp.848-859, 2004. ,
DOI : 10.1093/qjmed/hcg007
Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study, Gut, vol.43, issue.4, pp.494-498, 1998. ,
DOI : 10.1136/gut.43.4.494
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease, Gut, vol.51, issue.6, pp.808-813, 2002. ,
DOI : 10.1136/gut.51.6.808
Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature, The American Journal of Gastroenterology, vol.19, issue.4, pp.563-573, 2011. ,
DOI : 10.1136/bmj.280.6210.293-a
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes, Science, vol.107, issue.33, pp.105-108, 2011. ,
DOI : 10.1073/pnas.1005963107
URL : http://europepmc.org/articles/pmc3368382?pdf=render
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10
???/???
mice, Nature, vol.28, issue.7405, pp.104-108, 2012. ,
DOI : 10.1172/JCI118861
Gastrointestinal infection as a trigger for inflammatory bowel disease, Current Opinion in Gastroenterology, vol.28, issue.1, pp.24-29, 2012. ,
DOI : 10.1097/MOG.0b013e32834c453e
Yersinia pseudotuberculosis Effector YopJ Subverts the Nod2/RICK/TAK1 Pathway and Activates Caspase-1 to Induce Intestinal Barrier Dysfunction, Cell Host & Microbe, vol.11, issue.4, pp.337-351, 2012. ,
DOI : 10.1016/j.chom.2012.02.009
URL : https://hal.archives-ouvertes.fr/hal-01616773
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn???s disease, Gastroenterology, vol.127, issue.2, pp.412-421, 2004. ,
DOI : 10.1053/j.gastro.2004.04.061
Clinical trial: vitamin D3 treatment in Crohn???s disease - a randomized double-blind placebo-controlled study, Alimentary Pharmacology & Therapeutics, vol.16, issue.3, pp.377-383, 2010. ,
DOI : 10.1111/j.1365-2249.1995.tb03836.x
Crohn's Disease: A Two-Year Prospective Study of the Association Between Psychological Distress and Disease Activity, Digestive Diseases and Sciences, vol.49, issue.3, pp.492-497, 2004. ,
DOI : 10.1023/B:DDAS.0000020509.23162.cc
Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?, Alimentary Pharmacology and Therapeutics, vol.125, issue.10, pp.1035-1043, 2004. ,
DOI : 10.1046/j.1365-2036.2003.01596.x
Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study, PEDIATRICS, vol.130, issue.4, pp.794-803, 2012. ,
DOI : 10.1542/peds.2011-3886
The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis, The American Journal of Gastroenterology, vol.316, issue.6 Suppl, pp.2394-2400, 2008. ,
DOI : 10.1136/bmj.316.7124.61
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis, Annals of Internal Medicine, vol.156, issue.5, pp.350-359, 2012. ,
DOI : 10.7326/0003-4819-156-5-201203060-00007
Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1785-1794, 2011. ,
DOI : 10.1053/j.gastro.2011.01.055
URL : https://hal.archives-ouvertes.fr/hal-00631553
Recent trends in the epidemiology of inflammatory bowel diseases: Up or down, World Journal of Gastroenterology, vol.12, issue.38, pp.6102-6108, 2006. ,
DOI : 10.1111/j.1572-0241.2006.00381.x
New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe, Digestive and Liver Disease, vol.45, issue.4, pp.269-276, 2013. ,
DOI : 10.1016/j.dld.2012.08.020
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, vol.126, issue.6, pp.1504-1517, 2004. ,
DOI : 10.1053/j.gastro.2004.01.063
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)., Gut, vol.39, issue.5, pp.690-697, 1996. ,
DOI : 10.1136/gut.39.5.690
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data, Gastroenterology Inflamm. Bowel Dis, vol.14212, pp.46-54, 2006. ,
Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD), Digestive and Liver Disease, vol.45, issue.2, pp.89-94, 2013. ,
DOI : 10.1016/j.dld.2012.09.005
URL : https://hal.archives-ouvertes.fr/hal-01701899
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket, 1988. ,
Epidemiology and clinical course of Crohn's disease: Results from observational studies, World Journal of Gastroenterology, vol.18, issue.15, pp.1723-1731, 2012. ,
DOI : 10.3748/wjg.v18.i15.1723
Course of ulcerative colitis: Analysis of changes in disease activity over years, Gastroenterology, vol.107, issue.1, pp.3-11, 1994. ,
DOI : 10.1016/0016-5085(94)90054-X
Clinical Risk Factors for Complicated Disease: How Reliable Are They?, Digestive Diseases, vol.59, issue.s3, pp.67-72, 2012. ,
DOI : 10.1136/gutjnl-2011-300049
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study), Scandinavian Journal of Gastroenterology, vol.19, issue.2, pp.431-440, 2009. ,
DOI : 10.3109/00365529609004876
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time, The American Journal of Gastroenterology, vol.32, issue.170, pp.1564-1569, 1999. ,
DOI : 10.1136/gut.40.3.328
Clinical Course of Distal Ulcerative Colitis in Relation to Appendiceal Orifice Inflammation Status, Inflammatory Bowel Diseases, vol.37, issue.4, pp.366-371, 2005. ,
DOI : 10.1080/003655202753416849
Rectal Sparing and Skip Lesions in Ulcerative Colitis: A Comparative Study of Endoscopic and Histologic Findings in Patients Who Underwent Proctocolectomy, The American Journal of Surgical Pathology, vol.34, pp.689-696, 2010. ,
DOI : 10.1097/PAS.0b013e3181db84cd
Ulcerative Colitis and Colorectal Cancer, New England Journal of Medicine, vol.323, issue.18, pp.1228-1233, 1990. ,
DOI : 10.1056/NEJM199011013231802
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Montreal World Congress of Gastroenterology, pp.5-36, 2005. ,
DOI : 10.1155/2005/269076
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, vol.132, pp.763-786, 2007. ,
Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices, The American Journal of Gastroenterology, vol.48, issue.1, pp.162-169, 2008. ,
DOI : 10.1136/gut.48.4.526
Quels biomarqueurs et quelle place dans les MICI ?, pp.45-55, 2013. ,
Correlation of C-Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.128, issue.8, pp.707-712, 2005. ,
DOI : 10.1097/01.CRD.0000077906.74217.6E
Clinical and Laboratory Indicators of Extent of Ulcerative Colitis, Journal of Clinical Gastroenterology, vol.10, issue.1, pp.41-45, 1988. ,
DOI : 10.1097/00004836-198802000-00010
Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative Colitis, Inflammatory Bowel Diseases, vol.12, issue.3, pp.576-581, 2013. ,
DOI : 10.1097/01.MIB.0000225339.91484.fc
Role of faecal calprotectin as non-invasive marker of intestinal inflammation, Digestive and Liver Disease, vol.35, issue.9, pp.642-647, 2003. ,
DOI : 10.1016/S1590-8658(03)00381-5
Crohn??s disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn??s disease activity index and endoscopic findings, Inflammatory Bowel Diseases, vol.359, issue.1, pp.40-46, 2008. ,
DOI : 10.1016/S0140-6736(02)08512-4
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease, Gut, vol.49, issue.6, pp.777-782, 2001. ,
DOI : 10.1136/gut.49.6.777
Clinical Course in Crohn???s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study, Clinical Gastroenterology and Hepatology, vol.5, issue.12, pp.1430-1438, 2007. ,
DOI : 10.1016/j.cgh.2007.09.002
Predictors of Crohn???s Disease, Gastroenterology, vol.130, issue.3, pp.650-656, 2006. ,
DOI : 10.1053/j.gastro.2005.12.019
On the updated ECCO consensus guidelines for medical management of Crohn's disease, Journal of Crohn's and Colitis, vol.350, issue.Suppl 1, pp.165-166, 2011. ,
DOI : 10.1056/NEJMoa030815
Perianal Crohn's disease: Classification and clinical evaluation, Digestive and Liver Disease, vol.39, issue.10, pp.959-962, 2007. ,
DOI : 10.1016/j.dld.2007.07.153
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD, Gastrointestinal Endoscopy, vol.60, issue.4, pp.505-512, 2004. ,
DOI : 10.1016/S0016-5107(04)01878-4
Predictability of the postoperative course of Crohn's disease, Gastroenterology, vol.99, issue.4, pp.956-963, 1990. ,
DOI : 10.1016/0016-5085(90)90613-6
Développement d'un score de destruction digestive dans la maladie de Crohn, le score de Lémann, Hépato Gastro, vol.20, pp.25-32, 2013. ,
DOI : 10.1016/s0399-8320(09)72808-8
Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur, J. Gastroenterol. Hepatol, vol.19, pp.73-78, 2007. ,
Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study, World Journal of Gastroenterology, vol.9, issue.10, pp.2300-2307, 2003. ,
DOI : 10.1111/j.1572-0241.1998.156_b.x
Extraintestinal manifestations in inflammatory bowel disease, World Journal of Gastroenterology, vol.11, issue.46, pp.7227-7236, 2005. ,
DOI : 10.1111/j.1572-0241.2002.07093.x
Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease, World Journal of Gastroenterology, vol.15, issue.20, pp.2449-2455, 2009. ,
DOI : 10.3748/wjg.15.2449
Rheumatic manifestations in inflammatory bowel disease Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history, Autoimmun. Rev. Gut, vol.42, pp.387-391, 1998. ,
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association, J. Rheumatol, vol.27, pp.2860-2865, 2000. ,
Rheumatic manifestations of in???ammatory bowel disease, World Journal of Gastroenterology, vol.15, issue.44, pp.5517-5524, 2009. ,
DOI : 10.3748/wjg.15.5517
Joint Involvement Associated with Inflammatory Bowel Disease, Digestive Diseases, vol.27, issue.4, pp.511-515, 2009. ,
DOI : 10.1159/000233290
Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study, Clinical Rheumatology, vol.19, issue.6, pp.445-449, 2000. ,
DOI : 10.1007/s100670070003
Ankylosing spondylitis and bowel disease, Best Practice & Research Clinical Rheumatology, vol.20, issue.3, pp.451-471, 2006. ,
DOI : 10.1016/j.berh.2006.03.010
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis, Journal of Internal Medicine, vol.36, issue.1, pp.63-70, 2000. ,
DOI : 10.1007/BF02405286
Skin complications associated with inflammatory bowel disease, Alimentary Pharmacology and Therapeutics, vol.34, issue.s4, pp.50-53, 2004. ,
DOI : 10.1097/00054725-200403000-00013
Immune-Related Systemic Manifestations of Inflammatory Bowel Disease, Journal of Clinical Gastroenterology, vol.23, issue.1, pp.29-34, 1996. ,
DOI : 10.1097/00004836-199607000-00009
Are Perineal and Luminal Fistulas Associated in Crohn???s Disease? A Population-Based Study, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1130-1134, 2006. ,
DOI : 10.1016/j.cgh.2006.06.021
Crohn???s disease in Stockholm County during 1990-2001: An epidemiological update, World Journal of Gastroenterology, vol.12, issue.1 ,
DOI : 10.1136/gut.2004.047282
Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients, Gastroenterology, vol.114, issue.6, pp.1151-1160, 1998. ,
DOI : 10.1016/S0016-5085(98)70420-2
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases, G. Ital. Dermatol. E Venereol. Organo Uff. Soc. Ital. Dermatol. E Sifilogr, vol.148, pp.175-184, 2013. ,
Ocular Manifestations of Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.97, issue.2, pp.135-139, 2004. ,
DOI : 10.1111/j.1572-0241.2002.05514.x
Abnormal Hepatic Biochemistries in Patients With Inflammatory Bowel Disease, The American Journal of Gastroenterology, vol.30, issue.8, pp.344-350, 2007. ,
DOI : 10.1046/j.1365-2036.1996.92264000.x
Gallbladder Hypokinesia in Crohn???s Disease, Digestion, vol.58, issue.5, pp.458-463, 1997. ,
DOI : 10.1159/000201483
Pancréatites et maladies inflammatoires chroniques intestinales, pp.6-12, 2013. ,
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study, Gut, vol.60, issue.7, pp.937-943, 2011. ,
DOI : 10.1136/gut.2010.228585
Systematic review: managing anaemia in Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.50, issue.7, pp.1507-1523, 2006. ,
DOI : 10.1016/S0016-5085(99)70005-3
Anemia and inflammatory bowel diseases, World Journal of Gastroenterology, vol.15, issue.37, pp.4659-4665, 2009. ,
DOI : 10.3748/wjg.15.4659
The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, vol.48, issue.4, pp.526-535, 2001. ,
DOI : 10.1136/gut.48.4.526
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6 ,
DOI : 10.1016/j.cgh.2012.01.010
Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years, Gastroenterology, vol.143, issue.2, pp.375-381, 2012. ,
DOI : 10.1053/j.gastro.2012.04.016
Cancer risk in patients with inflammatory bowel disease, Cancer, vol.77, issue.4, pp.854-862, 2001. ,
DOI : 10.1097/00005792-199811000-00001
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.10, issue.2, pp.1097-1104, 2006. ,
DOI : 10.1080/00855910310001430
Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2729, 2005. ,
DOI : 10.1111/j.1572-0241.2003.08671.x
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations, J. Crohns Colitis. Available, vol.at, p.1873994612004060, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00742589
High lifetime risk of cancer in primary sclerosing cholangitis, Journal of Hepatology, vol.50, issue.1, pp.158-164, 2009. ,
DOI : 10.1016/j.jhep.2008.08.013
Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study, Gastroenterology, vol.133, issue.4, pp.1099-1105, 2007. ,
DOI : 10.1053/j.gastro.2007.08.001
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-1353, 2005. ,
DOI : 10.1097/00054725-200401000-00003
5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations, The American Journal of Gastroenterology, vol.107, issue.9, pp.1298-1304, 2012. ,
DOI : 10.1053/j.gastro.2010.02.007
Interobserver Variability in the Diagnosis of Ulcerative Colitis-Associated Dysplasia by Telepathology, Modern Pathology, vol.27, issue.Suppl VIII, pp.379-386, 2002. ,
DOI : 10.1016/S0046-8177(96)90363-9
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis, Alimentary Pharmacology & Therapeutics, vol.43, issue.2, pp.657-668, 2007. ,
DOI : 10.1016/0016-5085(92)91163-X
Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III), Journal of Crohn's and Colitis, vol.15, issue.20, 2013. ,
DOI : 10.1111/j.1524-4725.1989.tb03166.x
URL : https://hal.archives-ouvertes.fr/hal-00829286
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease, Gastroenterology, vol.141, issue.5, pp.1621-1628, 2011. ,
DOI : 10.1053/j.gastro.2011.06.050
URL : https://hal.archives-ouvertes.fr/hal-00631539
Mucosal Healing with Anti-TNF Antibodies, Digestion, vol.133, issue.s1, pp.16-22, 2012. ,
DOI : 10.1053/j.gastro.2007.08.001
URL : http://www.zora.uzh.ch/id/eprint/76211/1/Mucosal_healing_Chevaux_et_al_13.7.2012.pdf
Obtenir une cicatrisation muqueuse chez les patients atteints de maladie inflammatoire chronique intestinale : pourquoi et chez quels malades ?, pp.33-38, 2013. ,
Recommendations Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED), Endoscopy, vol.45, issue.11 ,
DOI : 10.1055/s-0033-1344783
URL : https://hal.archives-ouvertes.fr/hal-01701888
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease, Journal of Crohn's and Colitis, vol.50, issue.A-146, pp.477-483, 2011. ,
DOI : 10.1016/S0016-5107(99)80017-0
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort, Gastroenterology, vol.133, issue.2, pp.412-422, 2007. ,
DOI : 10.1053/j.gastro.2007.05.051
Importance of mucosal healing in ulcerative colitis, Inflammatory Bowel Diseases, vol.55, issue.2, pp.338-346, 2010. ,
DOI : 10.1136/gut.2005.081794
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, vol.126, issue.2, pp.451-459, 2004. ,
DOI : 10.1053/j.gastro.2003.11.010
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.8, issue.Suppl. 5, pp.304-312, 2011. ,
DOI : 10.1136/bmj.315.7109.629
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis, Gastroenterology, vol.124, issue.4, pp.880-888, 2003. ,
DOI : 10.1053/gast.2003.50146
The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials, Colorectal Disease, vol.59, issue.4, pp.416-420, 2012. ,
DOI : 10.1016/S0016-5107(04)00492-4
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis, Gut, vol.53, issue.2, pp.256-260, 2004. ,
DOI : 10.1136/gut.2003.016386
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis, Endoscopy, vol.39, issue.3, pp.216-221, 2007. ,
DOI : 10.1055/s-2007-966214
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease, Cochrane Database Syst. Rev. Online, p.279, 2006. ,
Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role, The American Journal of Gastroenterology, vol.30, issue.3, pp.705-711, 2000. ,
DOI : 10.1097/00000478-199804000-00001
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel, Alimentary Pharmacology and Therapeutics, vol.8, issue.10, pp.1009-1016, 2003. ,
DOI : 10.1053/crad.2000.0625
Crohn's disease: factors associated with exposure to high levels of diagnostic radiation, Gut, vol.57, issue.11, pp.1524-1529, 2008. ,
DOI : 10.1136/gut.2008.151415
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines, Journal of Crohn's and Colitis, vol.11, issue.Suppl. 2, pp.556-585, 2013. ,
DOI : 10.1097/01.mib.0000179211.03650.b6
URL : https://hal.archives-ouvertes.fr/hal-01704202
Dynamic Contrast-Enhanced MRI of the Bowel Wall for Assessment of Disease Activity in Crohn's Disease, American Journal of Roentgenology, vol.186, issue.5, pp.1384-1392, 2006. ,
DOI : 10.2214/AJR.04.1454
Inflammatory Bowel Disease Diagnosed with US, MR, Scintigraphy, and CT: Meta-analysis of Prospective Studies, Radiology, vol.247, issue.1, pp.64-79, 2008. ,
DOI : 10.1148/radiol.2471070611
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn???s disease, Abdominal Imaging, vol.49, issue.11???12, pp.417-424, 2008. ,
DOI : 10.1016/0016-5085(90)90613-6
Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis, The American Journal of Gastroenterology, vol.3, issue.6, pp.1240-1248, 2010. ,
DOI : 10.1136/bmj.315.7109.629
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED???ECCO consensus, Endoscopy, vol.41, issue.07, pp.618-637, 2009. ,
DOI : 10.1055/s-0029-1214790
Management of Crohn's Disease in Adults, The American Journal of Gastroenterology, vol.7, issue.2, pp.465-483, 2009. ,
DOI : 10.1002/ibd.20014
5-ASA therapy for active Crohn?s disease: Old friends, old data, and a new conclusion, Clinical Gastroenterology and Hepatology, vol.2, issue.5, pp.376-378, 2004. ,
DOI : 10.1016/S1542-3565(04)00121-1
Oral Pentasa in the treatment of active Crohn's disease: A metaanalysis of double-blind, placebo-controlled trials, Clin. Gastroenterol. Hepatol. Off. Clin. Pr. J. Am. Gastroenterol. Assoc, vol.2, pp.379-388, 2004. ,
Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis, The American Journal of Gastroenterology, vol.86, issue.4, pp.617-629, 2011. ,
DOI : 10.1056/NEJMoa0904492
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, pp.255-260, 2001. ,
DOI : 10.1053/gast.2001.26279
Azathioprine and 6-Mercaptopurine in Crohn Disease, Annals of Internal Medicine, vol.123, issue.2, pp.132-142, 1995. ,
DOI : 10.7326/0003-4819-123-2-199507150-00009
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis., BMJ, vol.305, issue.6844, pp.20-22, 1992. ,
DOI : 10.1136/bmj.305.6844.20
Methotrexate, European Journal of Gastroenterology & Hepatology, vol.15, issue.3, pp.225-231, 2003. ,
DOI : 10.1097/00042737-200303000-00003
Methotrexate for maintenance of remission in ulcerative colitis, Cochrane Database Syst. Rev. Online, vol.102, issue.12, p.7560, 2009. ,
DOI : 10.1111/j.1572-0241.2007.01474.x
Prévention et prise en charge des complications des immunosuppresseurs chez les patients atteints de maladies inflammatoires chroniques intestinales (MICI), pp.266-273, 2013. ,
Maladies inflammatoires chroniques de l'intestin et cancer colorectal : quel est vraiment le risque à l'ère des biothérapies ?, Hépato Gastro, vol.20, pp.325-334, 2013. ,
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?, The American Journal of Gastroenterology, vol.130, issue.2, pp.199-212, 2011. ,
DOI : 10.1053/j.gastro.2008.11.053
Maladie de Crohn en rémission : que se passe-t-il à l'arrêt de l'infliximab?, pp.128-132, 2012. ,
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial, The Lancet, vol.371, issue.9613, pp.660-667, 2008. ,
DOI : 10.1016/S0140-6736(08)60304-9
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, pp.1383-1395, 2010. ,
DOI : 10.1056/NEJMoa0904492
Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: the UC SUCCESS trial, Gastroenterology, 2011. ,
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease, Gastroenterology, vol.134, issue.4, pp.929-936, 2008. ,
DOI : 10.1053/j.gastro.2008.01.012
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-??) Inhibitors: Results of the REFURBISH Study, The American Journal of Gastroenterology, vol.1, issue.1 ,
DOI : 10.1056/NEJMoa0904492
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1646, 2012. ,
DOI : 10.1053/j.gastro.2006.11.015
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis, Inflammatory Bowel Diseases, vol.5, issue.2, pp.176-181, 2009. ,
DOI : 10.1016/j.cgh.2006.12.027
Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970???2004), The American Journal of Gastroenterology, vol.490, issue.11, pp.1693-1701, 1970. ,
DOI : 10.1136/gut.2005.082909
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients, Scandinavian Journal of Gastroenterology, vol.28, issue.7, pp.699-706, 1995. ,
DOI : 10.1136/gut.28.4.382
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn???s Disease After Resection Different from Ileo-Colonic, Journal of Gastrointestinal Surgery, vol.55, issue.1, pp.246-252, 2009. ,
DOI : 10.1016/0016-5085(85)90006-X
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence, Digestive and Liver Disease, vol.44, issue.6 ,
DOI : 10.1016/j.dld.2011.12.018
Review article: the natural history of postoperative Crohn's disease recurrence, Alimentary Pharmacology & Therapeutics, vol.152, issue.Suppl. 2, pp.625-633, 2012. ,
DOI : 10.1016/j.jss.2008.04.014
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection, Gastroenterology, vol.136, issue.2, pp.441-450, 2009. ,
DOI : 10.1053/j.gastro.2008.10.051
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort, Gastroenterology, vol.139, issue.4, pp.1147-1155, 2010. ,
DOI : 10.1053/j.gastro.2010.06.070
Are Patients with Inflammatory Bowel Disease Receiving Optimal Care?, The American Journal of Gastroenterology, vol.120, issue.4, pp.1357-1361, 2005. ,
DOI : 10.1111/j.1572-0241.2001.04042.x
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial, Gastroenterology, vol.142, issue.5, pp.1102-1111, 2012. ,
DOI : 10.1053/j.gastro.2012.01.035
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis, Gastroenterology, vol.146, issue.1, 2013. ,
DOI : 10.1053/j.gastro.2013.06.010
Hospitalisations and surgery in Crohn's disease, Gut, vol.61, issue.4, pp.622-629, 2012. ,
DOI : 10.1136/gutjnl-2011-301397
Gender differences in the response of colitis to smoking, Clinical Gastroenterology and Hepatology, vol.2, issue.1, pp.41-48, 2004. ,
DOI : 10.1016/S1542-3565(03)00290-8
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001, World Journal of Gastroenterology, vol.10, issue.3, pp.404-409, 2004. ,
DOI : 10.1111/j.1572-0241.1999.01156.x
Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study), Scandinavian Journal of Gastroenterology, vol.4, issue.4, pp.602-610, 2007. ,
DOI : 10.1023/B:DDAS.0000020506.84248.f9
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates, Gut, vol.59, issue.9, pp.1200-1206, 2010. ,
DOI : 10.1136/gut.2009.202101
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, Cochrane Database Syst. Rev, p.545, 2010. ,
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, Journal of Crohn's and Colitis, vol.136, issue.S1, pp.28-62, 2010. ,
DOI : 10.1007/s00384-008-0542-9
The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.35, issue.5, pp.513-521, 2013. ,
DOI : 10.1016/j.clinre.2010.11.007
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, The Lancet, vol.374, issue.9701, pp.1617-1625, 2009. ,
DOI : 10.1016/S0140-6736(09)61302-7
URL : https://hal.archives-ouvertes.fr/hal-00466312
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines, Alimentary Pharmacology & Therapeutics, vol.323, issue.10, pp.937-946, 2013. ,
DOI : 10.1136/bmj.323.7308.334
Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health, Gut, vol.61, issue.2, pp.241-247, 2012. ,
DOI : 10.1136/gutjnl-2011-300049
URL : https://hal.archives-ouvertes.fr/hal-00683372
The Natural History of Adult Crohn's Disease in Population-Based Cohorts, The American Journal of Gastroenterology, vol.132, issue.2, pp.289-297, 2010. ,
DOI : 10.1053/j.gastro.2008.09.053
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort, Gastroenterology, vol.139, issue.4, pp.1147-1155, 2010. ,
DOI : 10.1053/j.gastro.2010.06.070
Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970???2004), The American Journal of Gastroenterology, vol.490, issue.11, pp.1693-1701, 1970. ,
DOI : 10.1136/gut.2005.082909
Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis, Inflammatory Bowel Diseases, vol.55, 2013. ,
DOI : 10.1007/s10620-009-0749-9
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1646, 2012. ,
DOI : 10.1053/j.gastro.2006.11.015
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6, pp.639-645, 2012. ,
DOI : 10.1016/j.cgh.2012.01.010
Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2729, 2005. ,
DOI : 10.1111/j.1572-0241.2003.08671.x
Are Patients with Inflammatory Bowel Disease Receiving Optimal Care?, The American Journal of Gastroenterology, vol.120, issue.4, pp.1357-1361, 2005. ,
DOI : 10.1111/j.1572-0241.2001.04042.x
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease, Journal of Crohn's and Colitis, vol.50, issue.A-146 ,
DOI : 10.1016/S0016-5107(99)80017-0
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines, Journal of Crohn's and Colitis, vol.11, issue.Suppl. 2, pp.556-585, 2013. ,
DOI : 10.1097/01.mib.0000179211.03650.b6
URL : https://hal.archives-ouvertes.fr/hal-01704202
On the updated ECCO consensus guidelines for medical management of Crohn's disease, Journal of Crohn's and Colitis, vol.350, issue.Suppl 1, pp.165-166, 2011. ,
DOI : 10.1056/NEJMoa030815
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial, Gastroenterology, vol.142, issue.5, pp.1102-1111, 2012. ,
DOI : 10.1053/j.gastro.2012.01.035
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis, Gastroenterology, vol.146, issue.1, 2013. ,
DOI : 10.1053/j.gastro.2013.06.010
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data, Inflammatory Bowel Diseases, vol.12, issue.3, pp.218-226, 2006. ,
DOI : 10.1053/gast.2003.50021
URL : https://hal.archives-ouvertes.fr/hal-00466309
Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD), Digestive and Liver Disease, vol.45, issue.2, pp.89-94, 2013. ,
DOI : 10.1016/j.dld.2012.09.005
URL : https://hal.archives-ouvertes.fr/hal-01701899
Hospitalisations and surgery in Crohn's disease, Gut, vol.61, issue.4, pp.622-629, 2012. ,
DOI : 10.1136/gutjnl-2011-301397
Gender differences in the response of colitis to smoking, Clinical Gastroenterology and Hepatology, vol.2, issue.1, pp.41-48, 2004. ,
DOI : 10.1016/S1542-3565(03)00290-8
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between, 1977. ,
The changing pattern of Crohn???s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007), Alimentary Pharmacology & Therapeutics, vol.135, issue.10, pp.1133-1142, 1988. ,
DOI : 10.1053/j.gastro.2008.06.081
Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study), Scandinavian Journal of Gastroenterology, vol.4, issue.4, pp.602-610, 2007. ,
DOI : 10.1023/B:DDAS.0000020506.84248.f9
Predictors of Crohn???s Disease, Gastroenterology, vol.130, issue.3, pp.650-656, 2006. ,
DOI : 10.1053/j.gastro.2005.12.019
Clinical Course in Crohn???s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study, Clinical Gastroenterology and Hepatology, vol.5, issue.12, pp.1430-1438, 2007. ,
DOI : 10.1016/j.cgh.2007.09.002
Clinical Risk Factors for Complicated Disease: How Reliable Are They?, Digestive Diseases, vol.59, issue.s3, pp.67-72, 2012. ,
DOI : 10.1136/gutjnl-2011-300049
Crohn???s disease in Stockholm County during 1990-2001: An epidemiological update, World Journal of Gastroenterology, vol.12, issue.1, pp.75-81, 2006. ,
DOI : 10.1136/gut.2004.047282
Are Perineal and Luminal Fistulas Associated in Crohn???s Disease? A Population-Based Study, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1130-1134, 2006. ,
DOI : 10.1016/j.cgh.2006.06.021
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates, Gut, vol.59, issue.9, pp.1200-1206, 2010. ,
DOI : 10.1136/gut.2009.202101
Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis, The American Journal of Gastroenterology, vol.86, issue.4, pp.617-629, 2011. ,
DOI : 10.1056/NEJMoa0904492
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, pp.1383-1395, 2010. ,
DOI : 10.1056/NEJMoa0904492
Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: the UC SUCCESS trial, Gastroenterology, 2011. ,
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial, The Lancet, vol.371, issue.9613, pp.660-667, 2008. ,
DOI : 10.1016/S0140-6736(08)60304-9
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-??) Inhibitors: Results of the REFURBISH Study, The American Journal of Gastroenterology, vol.1, issue.1, pp.99-105, 2013. ,
DOI : 10.1056/NEJMoa0904492
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, Cochrane Database Syst. Rev, p.545, 2010. ,
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, Journal of Crohn's and Colitis, vol.136, issue.S1 ,
DOI : 10.1007/s00384-008-0542-9
Recommendations Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED), Endoscopy, vol.45, issue.11 ,
DOI : 10.1055/s-0033-1344783
URL : https://hal.archives-ouvertes.fr/hal-01701888
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel, Alimentary Pharmacology and Therapeutics, vol.8, issue.10, pp.1009-1016, 2003. ,
DOI : 10.1053/crad.2000.0625
The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.35, issue.5, pp.513-521, 2013. ,
DOI : 10.1016/j.clinre.2010.11.007
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, The Lancet, vol.374, issue.9701, pp.1617-1625, 2009. ,
DOI : 10.1016/S0140-6736(09)61302-7
URL : https://hal.archives-ouvertes.fr/hal-00466312